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Introduction: Turner Syndrome (TS) is caused by monosomy or structural abnormalities of the X chromosome,
with a prevalence of about 1/2000 females live birth. Most important clinical features of TS are short stature and
gonadal failure. Approximately one third of girls with TS may undergo spontaneous puberty. Here we report on the
case of a girl with a rare 45X0/47XXX mosaic TS exhibiting a precocious puberty.
Case report: The patient was diagnosed with TS at the age of 4 years, upon a diagnostic work-up for dysmorphic
features. Chromosome analysis revealed a mosaic karyotype (45X0/47XXX). She presented with normal height and
normal growth velocity so that Growth Hormone (GH) therapy was not started. She was referred to our
Department at the age of 7 years and 10 months, because of vaginal bleeding. A physical examination revealed a
Tanner stage III for breast and Tanner stage III for pubic hair development. Height and weight were within the
normal range for age. Psychological evaluation showed moderate global developmental delay, together with
emotional and social immaturity and reading difficulties. The growth rate was accelerated. Her bone age was 10
years. Pelvic ultrasound demonstrated increased size for age of both the uterus and the ovaries, with bilateral
ovarian follicles. GnRH stimulation test revealed pubertal response of gonadotropins (peak LH 22.5 mIU/ml). MRI of
the brain was normal. These clinical, radiologic and laboratory findings were consistent with a diagnosis of
idiopathic central precocious puberty; therefore, GnRH analog therapy was started, in order to slow pubertal
progression and to preserve adult stature. Furthermore, GH treatment was added to further improve adult height.
Conclusion: Our case highlights the possibility of precocious puberty as an atypical clinical feature of TS. Thus,
precocious puberty may occur in TS girls when a dosage compensation by the cell line with more than two X
chromosomes allows normal ovarian function. GnRH analog therapy in addition to GH treatment should be
recommended in TS girls with precocious puberty in order to slow pubertal progression and to preserve adult
stature.
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Turner syndrome (TS) is a relatively common chromo-
somal disorder caused by complete or partial X mono-
somy, with a prevalence of approximately 1/2000
females live births [1]. The genetic background of TS
is highly variable. The most frequent occurring karyo-
types are 45,X, karyotypes with an isochromosome of
X (i(Xq) or i(Xp)), the mosaic karyotype of 45,X/46XX,* Correspondence: salerno@unina.it
1Department of Pediatrics, Federico II University of Naples, Naples, Italy
Full list of author information is available at the end of the article
© 2012 Improda et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the orand karyotypes containing an entire Y chromosome or
parts thereof [2]. The mosaic TS karyotype occurs in
approximately 30% of all patients with TS [3]. Short
stature, gonadal dysgenesis and congenital malforma-
tions are the main clinical features, although a number
of others signs and symptoms are seen more fre-
quently with the syndrome [1]. Although in TS there
is not a clear genotype/phenotype correlation, girls
with mosaic TS who have a normal cell line, or an
extra X chromosome tend to exhibit milder pheno-
types [3].
Absent pubertal development and primary amenorrhea
occurs in most individuals with TS, due to accelerated lossl Ltd. This is an Open Access article distributed under the terms of the Creative
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brous strike by birth. Approximately one third of girls with
TS undergo spontaneous puberty, but only half of those
complete puberty with menarche. Spontaneous pregnan-
cies are rare (2-5%) [4]. A few rare cases of precocious pu-
berty have been described, mainly in girls with mosaic TS
(45X0/46XX or X structural abnormalities) [5-8].
We report on the first case of precocious puberty in a
45X0/47XXX mosaic TS.
Case report
A female child was born pre-term (32 weeks of gesta-
tion) with a birth weight of 2.900 kg and a length of 49
cm. Postnatal period was uneventful. She was diagnosed
with TS at the age of 4 years, upon a diagnostic work-up
for dysmorphic features. High resolution chromosome
analysis revealed a mosaic karyotype (55% 45X0/45%
47XXX); FISH analysis excluded Y-chromosome-specific
sequences. Her stature was normal and within the target
height, no other associated abnormalities were detected,
thus she was followed by the general pediatrician.
She was referred to our Department at the age of 7
years and 10 months, because of vaginal bleeding. A
physical examination revealed a Tanner stage III for
breast development, Tanner stage III for pubic hair de-
velopment, axillary hair and scoliosis. Height and weight
were within the normal range for age (height 126 cm,
25th percentile, and weight 26 kg, 25-50th percentile, re-
spectively). The growth rate was accelerated (12 cm/
year) (Figure 1). Psychological evaluation showed moder-
ate global developmental delay, together with emotional
and social immaturity and reading difficulties. Skeletal
maturation, evaluated by a left wrist x-ray was 10 years.
Pelvic ultrasound demonstrated increased size for age of
both the uterus (longitudinal diameter 53mm) and the
ovaries (right ovary volume 3 ml and left 3.3 ml) with bi-
lateral ovarian follicles. Abdominal and cardiac ultra-
sound, as well as routine hematological and biochemical
analysis were normal. Endocrine evaluation revealed
FSH levels 7.66 mIU/mL, LH levels 1.68 mIU/mL, and
slightly elevated estradiol levels (28.2 pg/mL). GnRH
stimulation test revealed pubertal response of gonado-
tropins with LH peak value of 22.5 mIU/ml and FSH
peak value of 17.8 mIU/mL. Furthermore, assessment of
thyroid function showed thyroid stimulating hormone
(TSH) 5.5 μΙU/mL (normal range: 0.3-4.2 μΙU/mL), with
normal levels of free T4 (1.25 ng/dl, normal range
0.8-1.7), and positive thyroid anti-TPO autoantibodies
(100 IU/l, normal value less than 35), thus suggesting a
condition of mild subclinical hypothyroidism in the
context of autoimmune thyroiditis [9-11]. Other auto-
immune diseases were ruled out by appropriate investi-
gations [12-15]. Serum IGF-1 level was within normal
limits. MRI of the brain was normal.These clinical, radiologic and laboratory findings were
consistent with a diagnosis of idiopathic central preco-
cious puberty; therefore, GnRH analog therapy was
started, in order to slow pubertal progression and to pre-
serve maximum adult stature [5,16]. Furthermore, GH
treatment was added to further improve adult height.
At the chronological age of 12 years and bone age of
13 years, GnRH analog therapy was discontinued, result-
ing in recovery of pubertal development which was com-
pleted by menarche at the age of 12 yr and 10 months.
She is now 13 years old, she is still receiving GH treat-
ment, her near final height is 150 cm, slightly below the
target height (Figure 1).
Discussion
We report on the first case of precocious puberty in a
TS with a rare 45X0/47XXX mosaic karyotype.
TS is associated with a constellation of potential ab-
normalities involving many organ systems, making it a
challenging disorder for health care providers and fam-
ilies. The genetic background of TS is highly variable.
About 30% of TS girls have a mosaic chromosomal
structure, with only 1% showing a 45X0/47XXX mosai-
cism [17]. The correlation between genotype and pheno-
type is not yet well understood, but generally patients
with a 45,X karyotype tend to have a more severe
phenotype than those who are mosaic with a normal cell
line [2].
Short stature, ovarian dysgenesis and infertility are
clinical hallmarks in the majority of patients with TS.
The incidence of spontaneous puberty in TS is reported
to be about one third. In an Italian retrospective multi-
center study, 33.5% of 522 patients older than 12 yr
with Turner syndrome presented spontaneous pubertal
development, but only 16.1% completed puberty with
menarche [18].
Precocious puberty in TS patients is very rare. To date,
only five cases have been reported in the Literature, four
of them showing mosaic TS and one a karyotype with
structural abnormality of one X chromosome [5-8].
To our knowledge this is the first case of precocious
puberty reported in a TS with a mosaic karyotype char-
acterized by a cell line with X chromosome monosomy
and a cell line with three copy of the X chromosome,
thus suggesting a post-zygotic unbalanced disjunction of
the sex chromosomes. In addition to precocious puberty,
our patient showed other peculiar clinical features, such
as normal height and neuro-psychological problems,
likely related to the quantitative proportion of 45X to
47XXX cell-lines in different tissues and organs [19].
Triple X syndrome (47XXX) is a sex chromosome an-
euploidy that occurs in approximately 1 in 1000 female
births. Although non-mosaic 47,XXX karyotypes are the
most frequent, mosaicism occurs in approximately 10%
Figure 1 Growth chart of our patient.
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47XXX or 47XXX/48XXXX, or in combination including
Turner syndrome cell lines such as 45X/47XXX or 45X/
46XX/47XXX. Clinical characteristics include epicanthal
folds, hypertelorism, upslanting palpebral fissures, clino-
dactyly, overlapping digits, pes planus and pectus excava-
tum. The majority of cases are asymptomatic with normal
pubertal onset and sexual development [20]. However,
pubertal abnormalities have been reported in Triple X
syndrome, ranging from premature ovarian insufficiency
[21] to precocious puberty [22,23].
Genes located on the proximal region of the short arm
of the X chromosome are important for normal ovarian
function and development and the haploinsufficiency of
these genes is thought to be implicated in the pathogen-
esis of gonadal dysgenesis associated with TS [24]. On
the contrary, spontaneous puberty has been reported
with a significantly higher frequency among mosaic TS
with cell lines having more than one X. These observa-
tions suggest a cardinal influence of the X chromosome
on the appearance of spontaneous puberty [18]. In keeping
with this, our case suggests that even precocious puberty
may occur in TS girls when a dosage compensation by the
cell line with more than two X chromosomes allows
normal ovarian function.
The pathogenetic mechanism for central precocious
puberty in sex chromosome aneuploidies, particularly in
TS, is still unclear. Abnormalities in the hypothalamic
feedback system, with increased levels of gonadotropins
to compensate for blunted ovarian function, or FSH
surge commonly seen in TS before the ovarian failure
have been hypothesized [7]. Elevated levels of TSH have
also been proposed as a mechanism in causing preco-
cious puberty in girls with TS, due to the interaction be-
tween TSH and human FSH receptor [25]. In our
patient it seems unlikely that the slightly increase in
TSH levels may be responsible for precocious puberty,
because TSH levels were stable over time and no other
functional abnormalities were detected.
The decision to treat with GnRH analog a condition
such as TS, generally associated with ovarian failure, is
challenging. The observation that untreated precocious
puberty is generally associated with impaired adult
height due to bone age advancement and that short stat-
ure is per se a hallmark of TS prompted us to undertake
a treatment with GnRH analog [26]. Again, despite a
normal GH secretion following a pharmacological
stimulation test [27], evidence indicates that a GH treat-
ment may improve adult height in TS as well as in other
syndromes [28,29]. For this reason, the initiation of GH
therapy is currently considered as soon as growth failure
is evidenced even though short stature is not present [4].
In our patient, GH therapy was not initially started due
to normal height and normal growth velocity. However,after the diagnosis of precocious puberty, GH therapy
was considered in order to improve adult height.
Conclusion
Our case highlights the possibility of precocious puberty
as an atypical clinical feature of TS. Precocious puberty
may occur in TS girls when a dosage compensation by
the cell line with more than two X chromosomes allows
normal ovarian function. GnRH analog therapy in
addition to GH treatment should be recommended in
TS girls with precocious puberty in order to slow puber-
tal progression and to preserve adult stature.
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